天然骨位与增量位种植体长期生物学并发症的系统评价与荟萃分析
本系统评价与荟萃分析比较了天然骨位与增量位种植体在平均观察至少10年后的生物学并发症和失败率。共纳入8项研究(5项病例系列、1项病例对照、1项横断面、1项RCT),未发现两种位点在任何结局变量上存在统计学显著差异(p > .05),但研究间异质性高,结论需谨慎解读。
要点
- 天然骨位与增量位种植体在生物学并发症和失败率上无显著差异(p > .05)。
- 纳入研究未直接针对聚焦问题,且病例定义和纳入标准异质性高。
- 缺乏直接比较两种位点的随机对照试验,证据质量有限。
核心结论
- 天然骨位与增量位种植体在生物学并发症和失败率上无统计学显著差异(p > .05)。
- 由于研究设计异质性高,荟萃分析结果应谨慎解读。
研究设计与样本
- 系统评价与荟萃分析,纳入5项病例系列、1项病例对照、1项横断面和1项RCT。
- 纳入标准为平均观察期至少10年的种植体,需明确种植体周围黏膜炎和种植体周围炎病例定义。
- 采用二分类随机效应模型进行荟萃分析,结果以森林图呈现加权均值和95%CI。
主要发现
- 未发现比较天然骨位与增量位种植体结局的随机对照试验。
- 在患者水平和种植体水平,任何结局变量均无统计学显著差异(p > .05)。
- 患者采样、生物学并发症病例定义和纳入标准方面存在高异质性。
关键数值与推荐
- 纳入研究需明确种植体周围黏膜炎和种植体周围炎病例定义。
- 采用Newcastle-Ottawa量表和Cochrane中心及CONSORT声明参数进行质量评估。
临床怎么用
- 当前证据不足以区分天然骨位与增量位种植体的长期生物学并发症风险。
- 临床决策应结合个体情况,并注意现有研究的异质性。
局限性
- 纳入研究未直接针对聚焦问题。
- 研究设计异质性高,影响结果解读。
- 缺乏直接比较两种位点的随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To investigate and compare the prevalence of biological complications and failure of implants placed in pristine vs. augmented sites after a mean observation period of at least 10 years. MATERIALS AND METHODS: The focused question "In patients with osseointegrated dental implants, are there differences in biological complications and implant failure at implants placed in pristine vs. augmented sites?" was addressed using the Population, Exposure, Comparison and Outcome criteria. Electronic and manual searches supplemented by the screening of the grey literature were carried out. A case definition of peri-implant mucositis and peri-implantitis had to be specified. The binary random-effects method was chosen to conduct meta-analyses. Results are presented as Forest plots with weighted mean values and 95% confidence intervals (CI). The I2 statistic test was applied to quantify heterogeneity. The Newcastle-Ottawa Scale and the parameters provided in the Cochrane Center and CONSORT statement were used for quality assessment. The results are reported according to the PRISMA guidelines. RESULTS: No randomized clinical trial (RCT) comparing the outcomes of implants placed in pristine vs. augmented sites was identified. Five case-series studies, one case-control study, one cross-sectional study and one RCT were eligible for qualitative and quantitative analyses. No statistically significant differences (p > .05) were observed between implants placed in pristine vs. augmented sites for any outcome variables both at patient and at implant levels, respectively. High heterogeneity concerning patient sampling, case definitions of biological complications and eligibility criteria was observed. CONCLUSION: The studies included in the present systematic review did not directly address the focused questions. Hence, the outcomes of the meta-analysis should be interpreted with caution due to high variability with respect to study design.
引用
- Salvi GE, Monje A, Tomasi C, et al. Long-term biological complications of dental implants placed either in pristine or in augmented sites: A systematic review and meta-analysis. Clin Oral Implants Res. 2018. PMID: 30328184. doi:10.1111/clr.13123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。